[For more diverse company information on the startups mentioned in this article, please visit Unicorn Factory's big data platform 'Data Lab'.]

"After selling Daily Hotel in 2019, I took a break for about a year. During that time, I visited a functional medicine hospital with the thought of living healthily, but it was expensive and not easily accessible. Ultimately, I concluded that nutrition, exercise, and sleep are the core elements, and if these could be addressed digitally, many more people could be helped to live healthier lives."
The CEO of Phylize, an ultra-personalized health management platform, Shin In-sik (CEO), stated that he embarked on serial entrepreneurship to solve the problem of increasing life expectancy due to advances in medical technology, while simultaneously extending the period people spend with diseases or discomfort. After taking a break following the sale of his first startup, Daily Hotel, to Yanolja, Shin (CEO) re-founded Phylize in 2021.
"One-stop health management through 'AI coaching'... Essential for advancing B2C feedback services"
Phylize launched its data infrastructure and a supplement recommendation model in 2022, then expanded its scope to become a tracking platform covering all aspects of wellness. By enhancing services such as blood sugar management based on continuous glucose monitors (CGMs), the company began offering paid subscription services featuring AI (artificial intelligence) coaching models in earnest from last year.
Phylize provides solutions that allow users to manage diet, exercise, and blood sugar—previously handled separately—within a single platform and receive coaching. The AI coach assists in comprehensively managing all aspects necessary for maintaining health.
The AI coach utilizes foundation models trained on medical data and individual health profiles to analyze various elements such as sleep, exercise, and diet, providing daily personalized missions. Users can also directly set up 'custom coaches' with diverse personas, including family members, romantic partners, or pets.
Unlike other digital healthcare companies focused on B2B (business-to-business) transactions, Phylize initially adopted a B2C (business-to-consumer) strategy targeting individual consumers directly. Shin (CEO) stated, "One insight I gained while founding and operating Daily Hotel is that if you can build a competitive model in the B2C space, it will also work in B2B." He added, "Only by undergoing rapid cycles of updates and feedback reflection with general users can we create powerful products."
Phylize's B2C strategy is reflected in the numbers. According to the company, user retention rates have increased approximately fourfold since the introduction of AI coaching, and as of April this year, cumulative registrations surpassed 1.5 million users.
Obesity drug market becomes an 'opportunity'... Aiming for leap to a global mega-platform

Most Phylize users start the service with weight loss as their goal. In fact, users have collectively lost more than 500 tons (t) of body weight, and the top 20% of users have lost an average of 7.8 kg. However, what Phylize ultimately aims for is not just weight loss but "a sustainable healthy life."
To achieve this, Phylize launched the wellness brand 'Routine'. Its first product, the 'Fasting Bar', helps users who practice intermittent fasting maintain a feeling of fullness without hunger while preserving the effects of fasting. Based on accumulated data, the company plans to expand its lineup of health functional food products containing essential nutrients needed by modern people.
Shin (CEO) stated, "Routine is a brand created to fill gaps in offline areas that cannot be covered by Phylize's platform services." He added, "We will continuously research and develop customized products that go beyond simple supplement recommendations and provide real help for health management based on user data."
Phylize views the recent popularity of GLP-1-based obesity treatments such as Wegovy and Mounjaro not as a threat but as an opportunity for business expansion. While medications can be effective in controlling appetite, issues such as muscle loss, protein deficiency, and nutritional imbalance that accompany them still remain.
Shin (CEO) noted, "People who previously did not engage in health management are now entering the realm of management through obesity treatments." He added, "We are preparing a feature within the first half of this year to record injection logs, dosage, and location in the Phylize app and provide AI coaching tailored to that data." This strategy aims to cover problems that cannot be solved by medication alone through digital services.
Having established a business model centered on paid subscriptions, Phylize plans to lay the groundwork for becoming a global platform through future additional investments.
Shin (CEO) stated, "If we secure follow-on investment, we plan to further enhance our AI services and utilize the funds to expand into global markets." He expressed his ambition: "Our ultimate goal is to leapfrog as the number one mega-platform in the wellness AI field both domestically and internationally, going beyond a simple healthcare app."
[MoneyToday startup media platform Unicorn Factory]